ArticleCancers2024

Daratumumab during Myeloma Induction Therapy Is Associated with Impaired Stem Cell Mobilization and Prolonged Post-Transplant Hematologic Recovery.

Julian Mehl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.